Track Categories
The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Throughout our lifetimes, our cells are genetically programmed to carry out a multitude of functions. Weary cells that die in a regular cycle must be replaced with new ones. A tumour, sometimes known as a "swelling," is the outcome of an uncontrollably expanding cell caused by faulty DNA. However, in the context of cancer, the phrase refers to abnormal tissue growth.
- Track 1-1 Genetic Mutations and Cancer
- Track 1-2 Tumour Microenvironment
- Track 1-3 Oncogenes and Tumour Suppressor Genes
- Track 1-4 Cell Signalling Pathways
- Track 1-5 Cancer Stem Cells
Finding and diagnosing cancer early on allows for treatment of the illness while it is still in its most manageable phases. In this method, sophisticated imaging technologies like MRI and CT scans are used in addition to screening tests including Pap smears, colonoscopies, and mammograms. Furthermore, new methods like genetic testing and liquid biopsies are improving the capacity to identify cancer earlier and with greater accuracy.
- Track 2-1 Screening Technique
- Track 2-2 Biomarkers in Early Detection
- Track 2-3 Imaging Technologies
- Track 2-4 Liquid Biopsies
- Track 2-5 Genetic Testing and Personalized Diagnosis
Cancer therapeutic techniques include a variety of treatments intended to specifically target and eradicate cancer cells. These include radiation treatment, which utilizes high-energy radiation to eliminate tumours, chemotherapy, which uses chemicals to kill or inhibit cancer cells, and targeted therapies, which target cancer cells directly based on their molecular or genetic makeup.
- Track 3-1 Chemotherapy
- Track 3-2 Radiation Therapy
- Track 3-3 Targeted Therapies
- Track 3-4 Immunotherapy
- Track 3-5 Hormonal Therapy
Precision medicine in cancer treatment customizes care according to the unique features of each patient's cancer, including its molecular, genetic, and phenotypic profiles. This method finds certain mutations and biomarkers that direct the choice of targeted medicines, guaranteeing more efficient and individualized treatment regimens. It does this by utilizing genome sequencing and other cutting-edge diagnostics.
- Track 4-1 Genomic Profiling
- Track 4-2 Tailored Drug Therapies
- Track 4-3 Personalized Treatment Plans
- Track 4-4 Pharmacogenomics
- Track 4-5 Clinical Trials and Data Integration
The study of genetic alterations that propel the onset and spread of cancer is known as cancer genetics. It investigates the roles that somatic changes and hereditary mutations play in the development, expansion, and metastasis of tumours.
- Track 5-1 Inherited Cancer Syndromes
- Track 5-2 Genetic Risk Assessment
- Track 5-3 Gene Editing Technologies
- Track 5-4 Epigenetics and Cancer
- Track 5-5 Genetic Counselling
Understanding how the immune system interacts with cancer cells and how this affects tumour growth and treatment response is the main goal of cancer immunology. It looks into how immune cells target cancer, how tumours avoid being detected by the immune system, and how immunotherapies like checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are being developed.
- Track 6-1 Tumour Antigens
- Track 6-2 Immune Checkpoint Inhibitors
- Track 6-3 CAR-T Cell Therapy
- Track 6-4 Cancer Vaccines
- Track 6-5 Tumour-Infiltrating Lymphocytes
The diagnosis and treatment of cancer in children and adolescents is the focus of paediatric oncology. This topic focuses on the particulars of cancer in younger individuals, such as tumour subtypes, side effects from treatment, and concerns with long-term survivorship.
- Track 7-1 Common Paediatric Cancers
- Track 7-2 Long-Term Effects of Treatment
- Track 7-3 Innovative Therapies
- Track 7-4 Supportive Care for Paediatric Patients
- Track 7-5 Family and Psychological Support
The term "hemologic cancer" describes tumours that start in the lymphatic, bone marrow, or blood. This group comprises diseases including multiple myeloma, which affects bone marrow plasma cells, lymphoma, which affects the lymphatic system, and leukaemia, which affects blood and bone marrow.
- Track 8-1 Leukaemia
- Track 8-2 Lymphomas
- Track 8-3 Multiple Myeloma
- Track 8-4 Bone Marrow Disorders
- Track 8-5 Advances in Hematologic Treatments
It is the mechanism via which cancer cells metastasize, or spread, from the initial tumour site to other areas of the body. This intricate procedure entails local invasion, penetration by the lymphatic or blood systems, travel to distant locations, and the formation of additional tumours in these areas.
- Track 9-1 Mechanisms of Metastasis
- Track 9-2 Metastatic Sites and Patterns
- Track 9-3 Targeting Metastatic Spread
- Track 9-4 Role of the Microenvironment
- Track 9-5 Experimental Models and Techniques
The goals of clinical trials and research are to improve patient care, find new medicines, and advance current medications. Clinical trials are closely monitored research projects that evaluate novel medications, treatments, or diagnostic techniques for safety, effectiveness, and best practices.
- Track 10-1 Designing Clinical Trials
- Track 10-2 Phases of Clinical Trials
- Track 10-3 Ethical Considerations
- Track 10-4 Data Analysis and Interpretation
- Track 10-5 Patient Recruitment and Retention
It entails finding, evaluating, and releasing novel cancer treatments onto the market. The first step in the procedure is to discover possible therapeutic targets by doing genetic and biological studies on cancer. Before moving on to clinical trials, which assess a new compound's safety, efficacy, and ideal dosage in humans, preclinical studies investigate the compound's effectiveness and safety in lab animals.
- Track 11-1 Preclinical Testing
- Track 11-2 Phase I, II, III Trials
- Track 11-3 Regulatory Approval
- Track 11-4 Post-Marketing Surveillance
- Track 11-5 Drug Repurposing
It entails tactics and measures meant to lower the chance of getting cancer. This entails making lifestyle adjustments including eating a balanced diet, exercising frequently, and staying away from recognized carcinogens like smoke and excessive drinking.
- Track 12-1 Lifestyle and Environmental Factors
- Track 12-2 Vaccination
- Track 12-3 Nutritional Interventions
- Track 12-4 Public Health Strategies
- Track 12-5 Genetic Risk Reduction
Aging and cancer are strongly associated because as people age, their genetic mutation load and cellular repair mechanisms gradually deteriorate, increasing their likelihood of getting cancer. When receiving cancer therapy, older persons may have particular difficulties, such as managing other medical conditions and possible adverse effects from medications.
- Track 13-1 Age-Related Cancer Risks
- Track 13-2 Geriatric Oncology
- Track 13-3 Treatment Considerations in Older Adults
- Track 13-4 Survivorship and Aging
- Track 13-5 Multidisciplinary Approaches
Innovative approaches to investigate and modify cancer cells at the molecular level are used in molecular and cellular strategies for cancer treatment. Important methods consist of:
- Track 14-1 CRISPR and Gene Editing
- Track 14-2 Single-Cell Sequencing
- Track 14-3 Proteomics and Metabolomics
- Track 14-4 High-Throughput Screening
- Track 14-5 Bioinformatics Tools
It places a strong emphasis on adjusting care and assistance to each patient's unique requirements and preferences. Personalized Treatment Plans, all-encompassing support, and active engagement are all part of this strategy.
- Track 15-1 Quality of Life Assessments
- Track 15-2 Palliative and Supportive Care
- Track 15-3 Patient-Physician Communication
- Track 15-4 Psychosocial Support
- Track 15-5 Patient Advocacy and Rights
The distribution causes, and trends of cancer within populations are studied by cancer epidemiology. It includes risk factor identification, surveillance, prevention, and incidence and prevalence analysis.
- Track 16-1 Cancer Incidence and Prevalence
- Track 16-2 Risk Factors and Correlations
- Track 16-3 Geographical Variations
- Track 16-4 Surveillance and Monitoring
- Track 16-5 Data Collection and Analysis
Cancerous growths related to skin, breast, liver, pancreatic, colon, or other cancers can be successfully removed with surgery. Surgical oncologists may remove adjacent lymph nodes, remove healthy tissue around malignant tumours, or remove all or part of the tumours while treating cancer.
- Track 17-1 Minimally Invasive Surgery
- Track 17-2 Robotic-Assisted Surgery
- Track 17-3 Oncological Resections
- Track 17-4 Reconstructive Surgery
- Track 17-5 Surgical Innovations and Outcomes
Radiation oncology or radiation therapies are other names for therapeutic radiology. It is the use of radiation therapy to treat cancer and other illnesses. The area of medicine dedicated to the diagnosis and treatment of cancer is called oncology. Many types of radiation are used to kill cancer cells by stopping them from proliferating.
- Track 18-1 Advanced Imaging Techniques
- Track 18-2 Interventional Radiology
- Track 18-3 Radiomics and Imaging Biomarkers
- Track 18-4 Radiotherapy Planning
- Track 18-5 Patient Safety and Quality Assurance
It includes research on the fundamental mechanisms of signal transduction linked to cell division and apoptosis, the modes of action of anti-neoplastic medications, the creation and discovery of new medications, the fundamental mechanisms of DNA damage tolerance and repair, and the creation of innovative gene therapy techniques.
- Track 19-1 Mechanisms of Drug Action
- Track 19-2 Pharmacokinetics and Pharmacodynamics
- Track 19-3 Toxicity and Side Effects
- Track 19-4 Drug Interactions
- Track 19-5 Novel Drug Classes
There is a strong correlation between nutrition and cancer because dietary decisions can affect cancer risk, treatment effectiveness, and general health both before and after cancer therapy. Important elements consist of:
- Track 20-1 Nutritional Needs During Treatment
- Track 20-2 Impact of Diet on Cancer Progression
- Track 20-3 Supplements and Complementary Therapies
- Track 20-4 Nutritional Counselling
- Track 20-5 Diet and Prevention
The focus of cancer survivorship is on the all-encompassing care and assistance required for those who have finished their cancer treatment. It entails managing long-term side effects, attending to both physical and emotional needs, and continuing to watch for recurrence. Plans for survivorship care are created to direct follow-up treatment and encourage a healthy lifestyle.
- Track 21-1 Long-Term Consequences of Cancer Therapy
- Track 21-2 Rehabilitation and Recovery
- Track 21-3 Survivorship Care Plans
- Track 21-4 Mental Health and Wellness
- Track 21-5 Community Resources and Support
Integrative oncology seeks to enhance patient care by combining conventional cancer treatments with complementary therapies. This approach blends standard medical treatments with practices such as acupuncture, meditation, and nutritional counselling, addressing the whole person-body, mind, and spirit.
- Track 22-1 Complementary Therapies
- Track 22-2 Mind-Body Practices
- Track 22-3 Combining Conventional and Alternative Medicine
- Track 22-4 Patient Preferences and Efficacy
- Track 22-5 Safety and Regulation
The term "health disparities in cancer" describes the uneven incidence and prognosis of the disease in various populations, which are frequently impacted by racial or ethnic background, socioeconomic level, and place of residence. Variations in cancer incidence, treatment results, and access to care can result from these inequities.
- Track 23-1 Access to Care
- Track 23-2 Socioeconomic Factors
- Track 23-3 Racial and Ethnic Disparities
- Track 23-4 Geographic Variations
- Track 23-5 Strategies for Equity
Global oncology focuses on the differences and difficulties that exist between various geographical areas when addressing cancer prevention, treatment, and research on a worldwide level. It entails working together internationally to exchange information, materials, and cancer prevention tactics.
- Track 24-1 Cancer Burden Worldwide
- Track 24-2 International Collaborative Research
- Track 24-3 Healthcare Infrastructure
- Track 24-4 Global Health Initiatives
- Track 24-5 Cultural Considerations in Treatment
Oncology's future paths promise to transform cancer therapy via technological and personalized medical breakthroughs. Among the innovations are the integration of machine learning and artificial intelligence for predictive analytics, early detection, and optimal treatment regimens.
- Track 25-1 Emerging Technologies
- Track 25-2 Innovations in Treatment
- Track 25-3 Next-Generation Sequencing
- Track 25-4 Artificial Intelligence and Machine Learning
- Track 25-5 Future Research Trends